EJNMMI Physics welcomes submissions on imaging and dosimetry for radionuclide-based therapy. Radionuclide therapy and molecular radiotherapy are established modalities for the treatment of certain cancer types. In recent years there has been a significant expansion of new therapy options, radiopharmaceuticals and applications. Dosimetry is an essential component in the treatment chain to maximize the delivered absorbed dose to cancerous tissue while minimizing the dose to healthy organs.
To highlight the rapid changes in this field and to address the remaining challenges, EJNMMI Physics is publishing an article collection on this topic. For this collection, we invite contributions on the many different aspects of imaging and dosimetry of radionuclides for therapeutic use.
This collection will describe recent advances in the field and the manuscripts can be state-of-the-art review papers or original research papers. These papers can have a multi-disciplinary approach but the primary focus should be on medical physics or engineering related aspects.
Hugo De Jong, University of Utrecht, Utrecht, Netherlands
Yuni Dewaraja, University of Michigan Medical School, Ann Arbor, United States
Gerhard Glatting, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
Michael Ljungberg, Lund University, Lund, Sweden
For editorial enquiries please contact email@example.com.